These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

198 related items for PubMed ID: 4133855

  • 1. Spontaneous tumor regression. Experimental aspects.
    McLaughlin AP, Gittes RF.
    Urology; 1974 May; 3(5):544-51. PubMed ID: 4133855
    [No Abstract] [Full Text] [Related]

  • 2. The fate of methylcholanthrene tumor cells in bone: analysis of immune factors in host resistance.
    McLaughlin AP, Kessler WO, Clark PL, Gittes RF.
    J Surg Res; 1973 Mar; 14(3):186-92. PubMed ID: 4702159
    [No Abstract] [Full Text] [Related]

  • 3. Humoral and cellular immune factors in the systemic control of artifically induced metastases in C3Hf mice.
    Vaage J.
    Cancer Res; 1973 Aug; 33(8):1957-65. PubMed ID: 4720805
    [No Abstract] [Full Text] [Related]

  • 4. The effect of splenectomy on fibrosarcoma "metastases" in lungs of mice.
    Milas L, Mujagic H.
    Int J Cancer; 1973 Jan 15; 11(1):186-90. PubMed ID: 4790835
    [No Abstract] [Full Text] [Related]

  • 5. The stimulatory effect of tumor bearing upon the T- and B-cell subpopulations of the mouse spleen.
    Konda S, Nakao Y, Smith RT.
    Cancer Res; 1973 Oct 15; 33(10):2247-56. PubMed ID: 4147496
    [No Abstract] [Full Text] [Related]

  • 6. Cellular basis for the immune response to methylcholanthrene-induced tumors in mice. Heterogeneity of effector cells.
    Kearney R, Basten A, Nelson DS.
    Int J Cancer; 1975 Mar 15; 15(3):438-50. PubMed ID: 1079792
    [Abstract] [Full Text] [Related]

  • 7. Immune response to sarcomas. A review.
    Weinert CR, McMaster JH, Ferguson RJ.
    Clin Orthop Relat Res; 1974 Mar 15; (102):207-16. PubMed ID: 4529323
    [No Abstract] [Full Text] [Related]

  • 8. [Demonstration of humoral antibodies after isologous immunization with a chemically induced mouse fibrosarcoma].
    Stück B.
    Z Krebsforsch; 1967 Mar 15; 69(3):236-52. PubMed ID: 4231721
    [No Abstract] [Full Text] [Related]

  • 9. The influence of host immunity on the arrest of circulating cancer cells, and its modification by neuraminidase.
    Weiss L, Glaves D, Waite DA.
    Int J Cancer; 1974 Jun 15; 13(6):850-62. PubMed ID: 4605279
    [No Abstract] [Full Text] [Related]

  • 10. The effect of polyinosinic-polycytidylic acid on the immune response of mice to antigenically distinct tumors.
    Fisher JC, Cooperband SR, Mannick JA.
    Cancer Res; 1972 May 15; 32(5):889-92. PubMed ID: 4336028
    [No Abstract] [Full Text] [Related]

  • 11. Tumor-specific immunity in 3-methylcholanthrene-induced murine fibrosarcomas. I. In vivo demonstration of immunity with three preparations of soluble antigens.
    Brannen GE, Adams JS, Santos GW.
    J Natl Cancer Inst; 1974 Jul 15; 53(1):165-75. PubMed ID: 4600504
    [No Abstract] [Full Text] [Related]

  • 12. Enhancement of tumour growth by lymphoid cells from mice treated with antilymphocyte globulin.
    Shellam GR, Fahey KJ.
    Adv Exp Med Biol; 1973 Jul 15; 29(0):411-7. PubMed ID: 4211985
    [No Abstract] [Full Text] [Related]

  • 13. Passive transfer of tumor-specific resistance to methylcholanthrene-induced sarcomas in rats.
    Ishikawa Y, Fukushima M, Sato T, Komaba M, Yagihashi H.
    Tohoku J Exp Med; 1971 Feb 15; 103(2):195-201. PubMed ID: 5580594
    [No Abstract] [Full Text] [Related]

  • 14. Immunological resistance to pulmonary metastases in C3Hf-Bu mice bearing syngeneic fibrosarcoma of different sizes.
    Milas L, Hunter N, Mason K, Withers HR.
    Cancer Res; 1974 Jan 15; 34(1):61-71. PubMed ID: 4809463
    [No Abstract] [Full Text] [Related]

  • 15. The present status of tumor immunology.
    Fisher B.
    Adv Surg; 1971 Jan 15; 5():189-254. PubMed ID: 4941820
    [No Abstract] [Full Text] [Related]

  • 16. Immunological enhancement of tumor growth by syngeneic thymus-derived lymphocytes.
    Umiel T, Trainin N.
    Transplantation; 1974 Sep 15; 18(3):244-50. PubMed ID: 4608685
    [No Abstract] [Full Text] [Related]

  • 17. Comparative effect of Mycobacterium bovis- and neuraminidase-treated tumor cells on the growth of established methylcholanthrene fibrosarcomas in syngeneic mice.
    Rios A, Simmons RL.
    Cancer Res; 1972 Jan 15; 32(1):16-21. PubMed ID: 4550256
    [No Abstract] [Full Text] [Related]

  • 18. Immunity to carcinogen-induced transplantable fibrosarcoma in B2/B2 chickens. V. Relationship to tumor cell-specific delayed hypersensitivity and serum antibody.
    Galton JE, Palladino MA, Xue B, Edelman AS, Thorbecke GJ.
    Cell Immunol; 1982 Nov 01; 73(2):247-63. PubMed ID: 6186403
    [No Abstract] [Full Text] [Related]

  • 19. Suppression of generation of concomitant antitumor immunity by passively transferred suppressor T cells from tumor-bearing donors.
    Bursuker I, North RJ.
    Cancer Immunol Immunother; 1985 Nov 01; 19(3):215-8. PubMed ID: 3159472
    [Abstract] [Full Text] [Related]

  • 20. The development of cellular immunity to tumor cells.
    Cerilli J, Smith MC.
    Surg Gynecol Obstet; 1972 May 01; 134(5):739-45. PubMed ID: 5064081
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.